Bone Biologics (BBLG) Short Interest Ratio & Short Volume $0.68 +0.01 (+1.45%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$0.68 -0.01 (-0.74%) As of 04/17/2025 05:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Bone Biologics Short Interest DataBone Biologics (BBLG) has a short interest of 89,900 shares, representing 16.85% of the float (the number of shares available for trading by the public). This marks a 17.52% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 1.40 million shares to cover all short positions.Current Short Interest89,900 sharesPrevious Short Interest76,500 sharesChange Vs. Previous Month+17.52%Dollar Volume Sold Short$71,920.00Short Interest Ratio0.5 Days to CoverLast Record DateMarch 31, 2025Outstanding Shares3,271,000 sharesFloat Size533,600 sharesShort Percent of Float16.85%Today's Trading Volume30,123 sharesAverage Trading Volume1,396,309 sharesToday's Volume Vs. Average2% Short Selling Bone Biologics? Sign up to receive the latest short interest report for Bone Biologics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBBLG Short Interest Over TimeBBLG Days to Cover Over TimeBBLG Percentage of Float Shorted Over Time Bone Biologics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202589,900 shares $71,920.00 +17.5%16.9%0.5 $0.80 3/15/202576,500 shares $63,495.00 -60.4%14.3%0.4 $0.83 2/28/2025193,300 shares $171,785.71 +48.2%36.2%0.9 $0.89 2/15/2025130,400 shares $135,616.00 -15.9%24.5%0.6 $1.04 1/31/2025155,000 shares $172,050.00 +105.0%29.1%0.8 $1.11 1/15/202575,600 shares $73,165.68 +37.2%14.2%0.4 $0.97 12/31/202455,100 shares $51,810.53 +9.8%10.3%0.2 $0.94 12/15/202450,200 shares $56,224.00 -28.7%9.4%0.2 $1.12 11/30/202470,400 shares $85,888.00 +21.0%13.2%0 $1.22 11/15/202458,200 shares $69,258.00 -19.3%10.9%0 $1.19 Get the Latest News and Ratings for BBLG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bone Biologics and its competitors with MarketBeat's FREE daily newsletter. 10/31/202472,100 shares $97,335.00 +48.4%13.8%0 $1.35 10/15/202448,600 shares $71,928.00 -86.2%9.3%0 $1.48 9/30/2024352,700 shares $751,251.00 +1,128.9%67.6%0.1 $2.13 9/15/202428,700 shares $22,960.00 +129.6%5.5%0 $0.80 8/31/202412,500 shares $17,500.00 -31.3%2.4%0 $1.40 8/15/202418,200 shares $26,754.00 -89.5%3.5%0 $1.47 7/31/2024172,900 shares $373,464.00 +3,162.3%33.6%0.1 $2.16 7/15/20245,300 shares $6,254.00 +562.5%1.0%0 $1.18 6/30/2024800 shares $976.00 -96.3%0.2%0 $1.22 6/15/202421,800 shares $32,918.00 +69.0%4.2%0.3 $1.51 5/31/202412,900 shares $21,414.00 -29.5%2.5%0.2 $1.66 5/15/202418,300 shares $41,541.00 -7.1%3.6%0.2 $2.27 4/30/202419,700 shares $30,761.55 +51.5%3.9%0.2 $1.56 4/15/202413,000 shares $20,930.00 -13.9%2.6%0.2 $1.61 3/31/202415,100 shares $32,163.00 -51.5%3.1%0.2 $2.13 3/15/202431,100 shares $72,463.00 -75.1%6.3%0.1 $2.33 2/29/2024124,800 shares $303,264.00 +625.6%23.5%0.5 $2.43 2/15/202417,200 shares $66,220.00 +65.4%3.2%0.1 $3.85 1/31/202410,400 shares $37,752.00 -75.4%2.0%0 $3.63 1/15/202442,300 shares $178,506.00 -25.7%8.0%0.1 $4.22 12/31/202356,900 shares $257,188.00 +1,397.4%10.7%0.2 $4.52 12/15/20233,800 shares $11,521.60 -92.6%1.1%0 $3.03 11/30/202351,600 shares $21,104.40 +1,257.9%1.9%0.1 $0.41 11/15/20233,800 shares $2,063.78 -59.1%0.1%0 $0.54 10/31/20239,300 shares $4,868.55 +121.4%0.3%0 $0.52 10/15/20234,200 shares $2,520.00 -71.6%0.2%0 $0.60 9/30/202314,800 shares $10,509.48 -35.1%0.5%0 $0.71 9/15/202322,800 shares $16,393.20 +200.0%0.8%0.1 $0.72 8/31/20237,600 shares $5,145.20 -29.6%0.3%0 $0.68 8/15/202310,800 shares $0.00 -57.0%0.4%0 $0.00Now I look stupid. Real stupid... (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. BBLG Short Interest - Frequently Asked Questions What is Bone Biologics' current short interest? Short interest is the volume of Bone Biologics shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 89,900 shares of BBLG short. 16.85% of Bone Biologics' shares are currently sold short. Learn More on Bone Biologics' current short interest. What is a good short interest percentage for Bone Biologics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 16.85% of Bone Biologics' floating shares are currently sold short. Is Bone Biologics' short interest increasing or decreasing? Bone Biologics saw a increase in short interest in March. As of March 31st, there was short interest totaling 89,900 shares, an increase of 17.5% from the previous total of 76,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Bone Biologics' float size? Bone Biologics currently has issued a total of 3,271,000 shares. Some of Bone Biologics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Bone Biologics currently has a public float of 533,600 shares. How does Bone Biologics' short interest compare to its competitors? 16.85% of Bone Biologics' shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Bone Biologics: NeuroMetrix, Inc. (0.04%), Intelligent Bio Solutions Inc. (8.06%), Predictive Oncology Inc. (11.93%), Meihua International Medical Technologies Co., Ltd. (0.13%), Inspira Technologies Oxy B.H.N. Ltd. (0.31%), DIH Holding US, Inc. (0.60%), Tenon Medical, Inc. (9.72%), Lyra Therapeutics, Inc. (3.86%), Star Equity Holdings, Inc. (1.03%), NanoVibronix, Inc. (12.96%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks. What does it mean to sell short Bone Biologics stock? Short selling BBLG is an investing strategy that aims to generate trading profit from Bone Biologics as its price is falling. BBLG shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Bone Biologics? A short squeeze for Bone Biologics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BBLG, which in turn drives the price of the stock up even further. How often is Bone Biologics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BBLG, twice per month. The most recent reporting period available is March, 31 2025. More Short Interest Resources from MarketBeat Related Companies NURO Short Interest Data INBS Short Interest Data POAI Short Interest Data MHUA Short Interest Data IINN Short Interest Data DHAI Short Interest Data TNON Short Interest Data LYRA Short Interest Data STRR Short Interest Data NAOV Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BBLG) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bone Biologics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bone Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.